Clinical Trial Update: Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating whether different infusion times of tislelizumab improve outcomes for patients with postoperative high-risk hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: RECRUITING